Cancer targeting Gene-Viro-Therapy specific for liver cancer by alpha-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24
文献类型：期刊论文
| 作者 | Cao, X; Wei, RC; Liu, XR; Zeng, Y; Huang, HL; Ding, M; Zhang, KJ; Liu, XY |
| 刊名 | ACTA BIOCHIMICA ET BIOPHYSICA SINICA
 |
| 出版日期 | 2011 |
| 卷号 | 43期号:10页码:813-821 |
| 关键词 | cancer biotherapy oncolytic adenovirus apoptosis suppressor of cytokine signaling 3 interleukin-24 |
| 通讯作者 | Liu, XY (reprint author), Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.,xyliu@sibs.ac.cn |
| 英文摘要 | The combination of gene therapy and virotherapy for cancer treatment has received close attention and has become a trend in the field of cancer biotherapy. A strategy called 'Cancer Targeting Gene-Viro-Therapy' (CTGVT) or 'Gene Armed Oncolytic Viral Therapy' (GAOVT) has been proposed, in which an antitumor gene is inserted into an oncolytic viral vector. In our previous study, a dual-regulated oncolytic adenovirus with enhanced safety for normal cells and strict liver cancer-targeting ability, designated Ad center dot enAFP center dot E1A center dot E1B (Delta 55) (briefly Ad center dot enAFP center dot D55), was successfully constructed. In the current work, interleukin-24 (IL-24) and suppressor of cytokine signaling 3 (SOCS3) genes were packaged into Ad center dot enAFP center dot D55. The new constructs, Ad center dot enAFP center dot D55-(IL-24) and Ad center dot enAFP center dot D55-(SOCS3), showed improved tumoricidal activity in hepatoma cell lines compared with the oncolytic viral vector Ad center dot enAFP center dot D55. The co-administration of Ad center dot enAFP center dot D55-(IL-24) and Ad center dot enAFP center dot D55-(SOCS3) showed much better antitumor effect than Ad center dot enAFP center dot D55-(IL-24) or Ad center dot enAFP center dot D55-(SOCS3) alone both in vitro and in a nude mouse xenograft model. Moreover, our results also showed that blockade of the Jak/ Stat3 pathway by Ad center dot enAFP center dot D55-(SOCS3) infection in HuH-7 cells could down-regulate some anti-apoptosis proteins, such as XIAP, Bcl-xL, and survivin, which might sensitize the cells to Ad center dot enAFP center dot D55-(IL-24)-induced apoptosis. These results indicate that co-administration of Ade center dot nAFP center dot D55-(IL-24) and Ad center dot enAFP center dot D55-(SOCS3) may serve as a candidate therapeutic approach for the treatment of liver cancer. |
| 学科主题 | Biochemistry & Molecular Biology; Biophysics |
| 类目[WOS] | Biochemistry & Molecular Biology ; Biophysics |
| 关键词[WOS] | LEBERS CONGENITAL AMAUROSIS ; HEPATOCELLULAR-CARCINOMA ; MDA-7/IL-24 ; JAK/STAT ; APOPTOSIS ; PATHWAYS ; CYTOKINE ; EFFICACY ; VECTOR ; GROWTH |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000295411300009 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.143/handle/331003/859]  |
| 专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
| 推荐引用方式 GB/T 7714 | Cao, X,Wei, RC,Liu, XR,et al. Cancer targeting Gene-Viro-Therapy specific for liver cancer by alpha-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24[J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA,2011,43(10):813-821. |
| APA | Cao, X.,Wei, RC.,Liu, XR.,Zeng, Y.,Huang, HL.,...&Liu, XY.(2011).Cancer targeting Gene-Viro-Therapy specific for liver cancer by alpha-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24.ACTA BIOCHIMICA ET BIOPHYSICA SINICA,43(10),813-821. |
| MLA | Cao, X,et al."Cancer targeting Gene-Viro-Therapy specific for liver cancer by alpha-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24".ACTA BIOCHIMICA ET BIOPHYSICA SINICA 43.10(2011):813-821. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。